Post-treatment serum Wisteria floribunda agglutinin-positive mac-2-binding protein level is a useful predictor of hepatocellular carcinoma development after hepatitis C virus eradication.

Wisteria floribunda agglutinin‐positive mac‐2‐binding protein direct‐acting antiviral drug hepatitis C virus hepatocellular carcinoma interferon‐based therapy interferon‐free therapy sustained virological response

Journal

JGH open : an open access journal of gastroenterology and hepatology
ISSN: 2397-9070
Titre abrégé: JGH Open
Pays: Australia
ID NLM: 101730833

Informations de publication

Date de publication:
Oct 2021
Historique:
received: 25 03 2021
revised: 18 08 2021
accepted: 03 09 2021
entrez: 8 10 2021
pubmed: 9 10 2021
medline: 9 10 2021
Statut: epublish

Résumé

Recent advances of direct-acting antiviral drugs for hepatitis C virus (HCV) have dramatically improved the sustained virologic response (SVR) rate, but hepatocellular carcinoma (HCC) development rarely occurs even in patients who achieve an SVR. Wisteria floribunda agglutinin-positive mac-2-binding protein (WFA We examined the association between WFA The assessment of liver fibrosis using the WFA

Identifiants

pubmed: 34622009
doi: 10.1002/jgh3.12655
pii: JGH312655
pmc: PMC8485411
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1203-1209

Informations de copyright

© 2021 The Authors. JGH Open published by Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.

Références

Hepatology. 2016 Jul;64(1):130-7
pubmed: 26946190
Clin Gastroenterol Hepatol. 2011 Jun;9(6):509-516.e1
pubmed: 21397729
Gastroenterology. 2018 Nov;155(5):1436-1450.e6
pubmed: 30031138
Am J Gastroenterol. 2001 Nov;96(11):3142-6
pubmed: 11721762
JAMA. 2012 Dec 26;308(24):2584-93
pubmed: 23268517
J Gastroenterol. 2015 Jan;50(1):76-84
pubmed: 24603981
J Hepatol. 2016 Oct;65(4):727-733
pubmed: 27349488
Hepatology. 2020 Jan;71(1):44-55
pubmed: 31222774
Int J Mol Sci. 2016 Dec 20;17(12):
pubmed: 27999409
World J Gastroenterol. 2016 Sep 7;22(33):7569-78
pubmed: 27672277
Clin Gastroenterol Hepatol. 2004 Jun;2(6):469-73
pubmed: 15181614
Gastroenterology. 2017 Jan;152(1):142-156.e2
pubmed: 27641509
J Hepatol. 2017 Dec;67(6):1204-1212
pubmed: 28802876
J Hepatol. 2018 Aug;69(2):461-511
pubmed: 29650333
Hepatology. 2007 Jul;46(1):32-6
pubmed: 17567829
Ann Intern Med. 2013 Mar 5;158(5 Pt 1):329-37
pubmed: 23460056
J Hepatol. 2010 May;52(5):652-7
pubmed: 20346533
Hepatol Res. 2019 Sep;49(9):990-1002
pubmed: 31364248
J Hepatol. 2016 Oct;65(4):856-858
pubmed: 27318327

Auteurs

Shunsuke Sato (S)

Department of Gastroenterology and Hepatology Juntendo University Shizuoka Hospital Shizuoka Japan.

Hironori Tsuzura (H)

Department of Gastroenterology and Hepatology Juntendo University Shizuoka Hospital Shizuoka Japan.

Yuji Kita (Y)

Department of Gastroenterology and Hepatology Juntendo University Shizuoka Hospital Shizuoka Japan.

Yuji Ikeda (Y)

Department of Gastroenterology and Hepatology Juntendo University Shizuoka Hospital Shizuoka Japan.

Daishi Kabemura (D)

Department of Gastroenterology and Hepatology Juntendo University Shizuoka Hospital Shizuoka Japan.

Sho Sato (S)

Department of Gastroenterology and Hepatology Juntendo University Shizuoka Hospital Shizuoka Japan.

Nozomi Amano (N)

Department of Gastroenterology and Hepatology Juntendo University Shizuoka Hospital Shizuoka Japan.

Noboru Yatagai (N)

Department of Gastroenterology and Hepatology Juntendo University Shizuoka Hospital Shizuoka Japan.

Ayato Murata (A)

Department of Gastroenterology and Hepatology Juntendo University Shizuoka Hospital Shizuoka Japan.

Yuji Shimada (Y)

Department of Gastroenterology and Hepatology Juntendo University Shizuoka Hospital Shizuoka Japan.

Takuya Genda (T)

Department of Gastroenterology and Hepatology Juntendo University Shizuoka Hospital Shizuoka Japan.

Classifications MeSH